Vesicle mediated transport, Qc-SNARE , putative
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | yes | yes: 18 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 10 |
| NetGPI | no | yes: 0, no: 10 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0012505 | endomembrane system | 2 | 1 |
| GO:0016020 | membrane | 2 | 7 |
| GO:0031201 | SNARE complex | 3 | 1 |
| GO:0032991 | protein-containing complex | 1 | 1 |
| GO:0098796 | membrane protein complex | 2 | 1 |
| GO:0110165 | cellular anatomical entity | 1 | 7 |
Related structures:
AlphaFold database: A4I201
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0006810 | transport | 3 | 8 |
| GO:0006886 | intracellular protein transport | 4 | 1 |
| GO:0006906 | vesicle fusion | 6 | 1 |
| GO:0006996 | organelle organization | 4 | 1 |
| GO:0008104 | protein localization | 4 | 3 |
| GO:0009987 | cellular process | 1 | 3 |
| GO:0015031 | protein transport | 4 | 3 |
| GO:0016043 | cellular component organization | 3 | 1 |
| GO:0016050 | vesicle organization | 5 | 1 |
| GO:0022406 | membrane docking | 2 | 1 |
| GO:0033036 | macromolecule localization | 2 | 3 |
| GO:0045184 | establishment of protein localization | 3 | 3 |
| GO:0046907 | intracellular transport | 3 | 1 |
| GO:0048278 | vesicle docking | 4 | 1 |
| GO:0048284 | organelle fusion | 5 | 1 |
| GO:0051179 | localization | 1 | 8 |
| GO:0051234 | establishment of localization | 2 | 8 |
| GO:0051640 | organelle localization | 2 | 1 |
| GO:0051641 | cellular localization | 2 | 3 |
| GO:0051649 | establishment of localization in cell | 3 | 1 |
| GO:0061024 | membrane organization | 4 | 1 |
| GO:0061025 | membrane fusion | 5 | 1 |
| GO:0070727 | cellular macromolecule localization | 3 | 3 |
| GO:0071702 | organic substance transport | 4 | 3 |
| GO:0071705 | nitrogen compound transport | 4 | 3 |
| GO:0071840 | cellular component organization or biogenesis | 2 | 1 |
| GO:0090174 | organelle membrane fusion | 6 | 1 |
| GO:0140056 | organelle localization by membrane tethering | 3 | 1 |
| GO:0016192 | vesicle-mediated transport | 4 | 7 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0000149 | SNARE binding | 3 | 1 |
| GO:0005484 | SNAP receptor activity | 3 | 1 |
| GO:0005488 | binding | 1 | 1 |
| GO:0005515 | protein binding | 2 | 1 |
| GO:0030674 | protein-macromolecule adaptor activity | 2 | 1 |
| GO:0060090 | molecular adaptor activity | 1 | 1 |
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_C14_Caspase3-7 | 138 | 142 | PF00656 | 0.622 |
| CLV_NRD_NRD_1 | 128 | 130 | PF00675 | 0.369 |
| CLV_NRD_NRD_1 | 215 | 217 | PF00675 | 0.312 |
| CLV_PCSK_KEX2_1 | 130 | 132 | PF00082 | 0.362 |
| CLV_PCSK_PC1ET2_1 | 130 | 132 | PF00082 | 0.424 |
| CLV_PCSK_SKI1_1 | 202 | 206 | PF00082 | 0.328 |
| CLV_PCSK_SKI1_1 | 80 | 84 | PF00082 | 0.357 |
| DEG_Nend_UBRbox_3 | 1 | 3 | PF02207 | 0.725 |
| DOC_MAPK_gen_1 | 178 | 186 | PF00069 | 0.568 |
| DOC_MAPK_gen_1 | 228 | 236 | PF00069 | 0.456 |
| DOC_MAPK_MEF2A_6 | 152 | 161 | PF00069 | 0.534 |
| DOC_MAPK_MEF2A_6 | 228 | 236 | PF00069 | 0.456 |
| DOC_USP7_MATH_1 | 21 | 25 | PF00917 | 0.748 |
| DOC_USP7_MATH_1 | 4 | 8 | PF00917 | 0.745 |
| LIG_14-3-3_CanoR_1 | 171 | 179 | PF00244 | 0.619 |
| LIG_Actin_RPEL_3 | 221 | 240 | PF02755 | 0.536 |
| LIG_AP2alpha_2 | 28 | 30 | PF02296 | 0.570 |
| LIG_EH1_1 | 237 | 245 | PF00400 | 0.421 |
| LIG_FHA_2 | 23 | 29 | PF00498 | 0.714 |
| LIG_FHA_2 | 83 | 89 | PF00498 | 0.553 |
| LIG_FHA_2 | 94 | 100 | PF00498 | 0.542 |
| LIG_GBD_Chelix_1 | 241 | 249 | PF00786 | 0.376 |
| LIG_TRAF2_1 | 96 | 99 | PF00917 | 0.570 |
| MOD_CK2_1 | 21 | 27 | PF00069 | 0.708 |
| MOD_CK2_1 | 82 | 88 | PF00069 | 0.546 |
| MOD_CK2_1 | 93 | 99 | PF00069 | 0.542 |
| MOD_GlcNHglycan | 173 | 176 | PF01048 | 0.419 |
| MOD_GSK3_1 | 13 | 20 | PF00069 | 0.719 |
| MOD_GSK3_1 | 51 | 58 | PF00069 | 0.622 |
| MOD_GSK3_1 | 89 | 96 | PF00069 | 0.655 |
| MOD_NEK2_1 | 221 | 226 | PF00069 | 0.470 |
| MOD_NEK2_1 | 51 | 56 | PF00069 | 0.648 |
| MOD_PIKK_1 | 189 | 195 | PF00454 | 0.581 |
| MOD_PIKK_1 | 4 | 10 | PF00454 | 0.700 |
| MOD_PKA_1 | 216 | 222 | PF00069 | 0.523 |
| MOD_PKA_2 | 170 | 176 | PF00069 | 0.596 |
| MOD_PKA_2 | 51 | 57 | PF00069 | 0.677 |
| MOD_Plk_1 | 165 | 171 | PF00069 | 0.591 |
| MOD_Plk_2-3 | 165 | 171 | PF00069 | 0.591 |
| MOD_Plk_4 | 157 | 163 | PF00069 | 0.665 |
| MOD_Plk_4 | 55 | 61 | PF00069 | 0.567 |
| TRG_DiLeu_BaEn_2 | 145 | 151 | PF01217 | 0.594 |
| TRG_ER_diArg_1 | 129 | 132 | PF00400 | 0.587 |
| TRG_NES_CRM1_1 | 198 | 212 | PF08389 | 0.536 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A0N0P4C8 | Leptomonas seymouri | 27% | 100% |
| A0A0N1IK90 | Leptomonas seymouri | 77% | 97% |
| A0A0S4JJL1 | Bodo saltans | 42% | 100% |
| A0A1X0NSP4 | Trypanosomatidae | 54% | 100% |
| A0A3Q8IBW4 | Leishmania donovani | 31% | 100% |
| A0A3Q8IDN9 | Leishmania donovani | 100% | 100% |
| A0A3R7KG01 | Trypanosoma rangeli | 59% | 100% |
| A4HES4 | Leishmania braziliensis | 84% | 100% |
| A4HZL4 | Leishmania infantum | 30% | 100% |
| E9AY48 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 90% | 100% |
| O43752 | Homo sapiens | 29% | 98% |
| O60499 | Homo sapiens | 26% | 100% |
| Q4Q9C5 | Leishmania major | 95% | 100% |
| Q5R6Q2 | Pongo abelii | 29% | 98% |
| Q63635 | Rattus norvegicus | 32% | 98% |
| Q946Y7 | Arabidopsis thaliana | 28% | 100% |
| Q9JKK1 | Mus musculus | 31% | 98% |
| V5BUP0 | Trypanosoma cruzi | 56% | 100% |